OYMotion - 上海傲意信息科技有限公司
Shanghai bionic-hand and EMG-interface maker whose FDA-cleared OHand prosthetic and ROHAND dexterous hand serve rehabilitation and robotic manipulation markets.
OYMotion (Shanghai Aoyi Information Technology Co., Ltd.) is a Shanghai-based developer of bionic hands, robotic dexterous hands, and electromyography (EMG) interface hardware, founded in 2015. The company's roots trace to early surface-EMG sensing work, with a first EMG sensor prototype completed in 2013 and the initial version of its gForce EMG armband finished in 2016. OYMotion was certified as a national High-Tech Enterprise in 2018 and has since been designated a Shanghai "Specialized and Innovative" SME; it holds more than 80 authorized patents covering muscle-signal decoding, micro-actuator control, and lightweight composite hand structures.
The company's flagship product is the OHand intelligent bionic hand, a prosthetic device built from more than 280 mechanical components and driven by five miniature motors that allow each finger to move independently; OHand received FDA clearance in 2023. A lighter variant, OHand-Lite, is sized for smaller users such as women, teenagers, and children. A separate Quick-Change Wrist Bionic Hand model offers 11 joints and 6 degrees of freedom, supports 27 everyday grasp patterns, and carries a rated payload of 5 kg. For industrial and research applications, OYMotion also sells the ROHAND robotic dexterous hand, which adds integrated 3D tactile sensing for object manipulation tasks. On the sensing side, the gForce Ultra EMG armband reads forearm muscle signals for prosthetic control and human-machine interaction, complemented by a ShuBrain consumer EEG headband and a Finger Rehabilitation Exoskeleton Robot for stroke and nerve-injury recovery.
OYMotion is headquartered in Pudong, Shanghai, with an additional office in Hefei and a subsidiary established in Zhuhai in 2024. Financing has progressed through an angel round backed by Pudong Science and Innovation Group, a 2017 Pre-A round from Xiamen-based investors, a 2019 Series A led by Guangfa Xinde and Guangzhou Guofa, and a Series C1 round completed in 2026.
The company's rehabilitation and manipulation research has been referenced in connection with institutions including the Shirley Ryan AbilityLab in Chicago, Johns Hopkins University Applied Physics Laboratory, and the German Aerospace Center (DLR). OYMotion sells through direct channels, an official online storefront, and maintains a public developer site offering SDKs for its EMG sensor hardware.
Primary type & automation activities this supplier delivers:
OHand Intelligent Bionic Hand
Prosthetic bionic hand built from 280+ components driven by 5 micro motors enabling independent finger control; FDA-cleared in 2023.
Quick-Change Wrist Bionic Hand
EMG-driven prosthetic hand with 11 joints and 6 DOF, supporting 27 grasp patterns with a 5 kg rated payload and quick-release wrist mount.
ROHAND Robotic Dexterous Hand
Industrial-grade robotic dexterous hand with integrated 3D tactile sensing for object manipulation tasks.
Contact OYMotion
WEBSITE
https://www.oymotion.com/PHONE
+86 21-63210200HEADQUARTERS
China
Company Facts
Founded
2015
Primary Role
Manufacturer
Company Size
-
Primary Region
Asia-Pacific
Annual Sales
-
Funding Stage
Growth / Late-Stage VC
Funding Total
-
Certifications & Memberships
Keywords
- OYMotion
- 上海傲意信息科技有限公司
- Shanghai Aoyi Information Technology Co.
- Ltd.
- EMG sensing
- muscle-signal decoding
- bionic hand
- prosthetic hand
- tactile sensing
- EEG headband
- stroke recovery
- micro-actuator control
- Manufacturer
- Component Supplier
- End-effector & Grasping
- Exoskeleton
- Human-Machine Interaction
- Healthcare & Senior Care
- Manufacturing
